Hypertension preserves the magnitude of microvascular flow-mediated dilation following transient elevation in

William E Hughes1,2, Natalya Zinkevich2,3, David D Gutterman1,2,4

  • 1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Physiological Reports
|February 15, 2021
PubMed

Insights

Transient increases in intraluminal pressure impair flow-mediated dilation (FMD) in coronary artery disease (CAD) and non-CAD arterioles. However, hypertension preserves FMD by shifting the dilation mechanism from nitric oxide (NO) to hydrogen peroxide (H2O2).

Area of Science:

  • Vascular Physiology
  • Cardiovascular Research
  • Hypertension Studies

Background:

  • Flow-mediated dilation (FMD) assesses endothelial function, crucial for cardiovascular health.
  • Coronary artery disease (CAD) and hypertension are major risk factors for endothelial dysfunction.
  • Understanding how pressure changes affect FMD in different patient groups is vital for cardiovascular disease management.

Purpose of the Study:

  • To investigate the impact of transient increases in intraluminal pressure (IILP) on FMD in resistance arterioles.
  • To compare the response of arterioles from non-CAD, CAD, and hypertensive non-CAD individuals.
  • To elucidate the underlying mechanisms of FMD changes under simulated hypertensive conditions.

Main Methods:

  • Resistance arterioles were isolated from human adipose and atrial tissues.
  • IILP was simulated by applying 150 mmHg for 30 minutes.
  • FMD and endothelial-independent dilation were measured before and after IILP exposure, with pharmacological interventions (L-NAME, peg-cat) used to probe dilation pathways.

Main Results:

  • IILP significantly reduced FMD in both non-CAD and CAD arterioles.
  • Arterioles from hypertensive non-CAD subjects showed no reduction in maximal FMD after IILP.
  • In hypertensive non-CAD arterioles, nitric oxide (NO) mediated FMD pre-IILP, while hydrogen peroxide (H2O2) mediated it post-IILP.

Conclusions:

  • Acute exposure to increased intraluminal pressure attenuates FMD in resistance arterioles from non-CAD and CAD individuals.
  • Hypertension in non-CAD individuals preserves FMD magnitude following IILP due to a compensatory shift from NO to H2O2 signaling.
  • These findings highlight a protective mechanism in hypertensive individuals that warrants further investigation in cardiovascular health.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
331
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
331
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.7K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.6K